.png)
Built on engineering conviction.
Operated from Copenhagen.
A Danish pharmaceutical engineering group with rigorous European standards. One group, two specialists, no translation layer.
Who we are.
Damgaard Group is a Danish pharmaceutical engineering holding company based in Birkerød, near Copenhagen. We operate two distinct entities serving European and global pharmaceutical markets with uncompromising standards.
How we operate.
We are based in Birkerød, a short distance from Copenhagen, where we maintain the headquarters that coordinates both entities. The holding company model means each entity operates with full autonomy in its market while sharing a common commitment to compliance, senior-led delivery, and relationships that endure beyond the project close.
Vendor neutral
No equipment resale incentives. We specify what fits the project, recommend what works for your manufacturing context, and design what passes inspection.
Long-term relationships
We measure success in years, not milestones. Clients know exactly who they are working with and can rely on continuity through validation, qualification, and sustained operations.
The group portfolio.
Each entity has a distinct buyer, solves a distinct problem, and operates a distinct revenue model.
Damgaard Solutions.
Named specialists embedded from project kickoff through IQ/OQ/PQ validation. We bring five core specialisms — aseptic isolator filling, environmental monitoring, clean utilities, pharma robotics, and washing systems — with fluency in EU GMP Annex 1 and international regulatory requirements. Reference work includes Novo Nordisk Måløv 2023-24 and Bavarian Nordic Kvistgaard 2022-23.
- Aseptic isolator filling
- Environmental monitoring
- Clean utilities
- Pharma robotics
- Washing systems
Catalyst Reactivate.
The world's first pharmaceutical-grade H₂O₂ catalyst reactivation service for GMP cleanroom isolators. Stop replacing. Start reactivating. Every batch receives ISO 15202 ICP-OMS accredited third-party testing with zero residuals validated, plus QMS-compatible documentation with every order.
Visit Catalyst ReactivateRegulatory aligned
EU GMP Annex 1, FDA, EMA, and international regulatory frameworks understood and applied across current engagements.
Decision timeline
Three to six months typical for European pharmaceutical procurement cycles. Faster paths available for confidential studies.
Language capability
English documentation standard. Danish and additional language capability available for site documentation.
Direct access
Senior leadership available for substantive client conversations. European track record at Novo Nordisk and Bavarian Nordic anchors credibility.
Start a confidential conversation.
Tell us what you are building.